FDA approves a new kind of drug to prevent a second stroke
The FDA has approved asundexian, sold by Bayer as Sunharbo, for people who have just had a mild or moderate stroke. It is the first of a new type of blood thinner. In a trial of 12,327 patients, 6.2% on the drug had another stroke, against 8.4% on a dummy pill. Gut bleeding was a little more common.
Where this came from. 2 outlets reported this. We read them, then wrote the sixty words above.